Literature DB >> 1261159

Absorption and excretion of tolemetin in man.

W A Cressman, G F Wortham, J Plostnieks.   

Abstract

Tolmetin, a nonsteroidal anti-inflammatory drug, is rapidly absorbed (10 to 20 min) and rapidly excreted (T1/2 congruent to 60 min) and shows a linear dose-plasma level response in the therapeutic dose range. Tolmetin does not affect its own metabolism on chronic administration. Tolmetin is displaced, in vitro, from plasma proteins by salicylic acid. This effect is reflected in minor changes in plasma levels and pharmacokinetic parameters when aspirin and tolmetin are coadministered.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1261159     DOI: 10.1002/cpt1976192224

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

Review 1.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 2.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 3.  Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

4.  Protein binding of non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  M L Selley
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

Review 5.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

6.  Pharmacokinetics and metabolism of tolmetin in normal and adjuvant arthritic Lewis rats.

Authors:  J M Grindel; B H Migdalof; K A Yorgey; J F Pritchard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

7.  Pharmacokinetics of tolmetin with and without concomitant administration of antacid in man.

Authors:  J W Ayres; D J Weidler; J MacKichan; E Sakmar; M R Hallmark; E F Lemanowicz; J G Wagner
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

Review 8.  Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.

Authors:  C Durnas; B J Cusack
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

Review 9.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

10.  Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.

Authors:  J C Ojingwa; H Spahn-Langguth; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.